Pharmacological Treatment of Postprandial Reductions in Blood Pressure: A Systematic Review

Alice C. L. Ong, Phyo K. Myint, John F. Potter

Research output: Contribution to journalArticle

9 Citations (Scopus)
6 Downloads (Pure)

Abstract

OBJECTIVES: To systematically review the current literature on the pharmacological treatment of postmeal reductions in blood pressure (BP).

DESIGN: A systematic literature search and standardized data collection of randomized controlled trials on the pharmacological prevention of postprandial reductions in BP in adults using MEDLINE (1950-), EMBASE (1980-), and CINAHL databases was conducted up to July 2013. Bibliographies of relevant reports were also hand-searched to identify all potentially eligible studies.

SETTING: Systematic review of randomized controlled trials using PRISMA guidelines.

MEASUREMENTS: Articles were assessed using the Critical Appraisal Skills Programme for randomized controlled trials.

RESULTS: Thirteen articles reporting 12 studies (1 study was reported in 2 articles) demonstrated that caffeine (5 studies); acarbose; 3,4-DL-threo-dihydroxyphenylserine; guar gum (3 studies); and octreotide (2 studies) statistically attenuated the postprandial reduction in BP. One caffeine study did not show this. Most studies did not include individuals with symptomatic postprandial hypotension (PPH), so interpretation and application of these findings to this patient group should be made with caution. For symptomatic participants, there was improvement with acarbose but none with caffeine. Differences in the way the data were presented in the studies did not allow for quantification of treatment effects using meta-analysis.

CONCLUSION: Drug interventions can attenuate postprandial reductions in BP, but they may not necessarily be effective in people with symptomatic PPH.

Original languageEnglish
Pages (from-to)649-661
Number of pages13
JournalJournal of the American Geriatrics Society
Volume62
Issue number4
Early online date17 Mar 2014
DOIs
Publication statusPublished - Apr 2014

Fingerprint

Caffeine
Pharmacology
Acarbose
Blood Pressure
guar gum
Randomized Controlled Trials
Hypotension
Droxidopa
Octreotide
Bibliography
Therapeutics
MEDLINE
Meta-Analysis
Databases
Guidelines
Pharmaceutical Preparations

Keywords

  • drug treatment
  • pharmacological treatment
  • postprandial hypotension
  • blood pressure
  • central nervous system stimulants
  • female
  • humans
  • postprandial period
  • treatment outcome

Cite this

Pharmacological Treatment of Postprandial Reductions in Blood Pressure : A Systematic Review. / Ong, Alice C. L. ; Myint, Phyo K.; Potter, John F. .

In: Journal of the American Geriatrics Society, Vol. 62, No. 4, 04.2014, p. 649-661.

Research output: Contribution to journalArticle

@article{3453f090a19949b4b6e7b52f0c1064d6,
title = "Pharmacological Treatment of Postprandial Reductions in Blood Pressure: A Systematic Review",
abstract = "OBJECTIVES: To systematically review the current literature on the pharmacological treatment of postmeal reductions in blood pressure (BP). DESIGN: A systematic literature search and standardized data collection of randomized controlled trials on the pharmacological prevention of postprandial reductions in BP in adults using MEDLINE (1950-), EMBASE (1980-), and CINAHL databases was conducted up to July 2013. Bibliographies of relevant reports were also hand-searched to identify all potentially eligible studies. SETTING: Systematic review of randomized controlled trials using PRISMA guidelines. MEASUREMENTS: Articles were assessed using the Critical Appraisal Skills Programme for randomized controlled trials. RESULTS: Thirteen articles reporting 12 studies (1 study was reported in 2 articles) demonstrated that caffeine (5 studies); acarbose; 3,4-DL-threo-dihydroxyphenylserine; guar gum (3 studies); and octreotide (2 studies) statistically attenuated the postprandial reduction in BP. One caffeine study did not show this. Most studies did not include individuals with symptomatic postprandial hypotension (PPH), so interpretation and application of these findings to this patient group should be made with caution. For symptomatic participants, there was improvement with acarbose but none with caffeine. Differences in the way the data were presented in the studies did not allow for quantification of treatment effects using meta-analysis. CONCLUSION: Drug interventions can attenuate postprandial reductions in BP, but they may not necessarily be effective in people with symptomatic PPH.",
keywords = "drug treatment, pharmacological treatment, postprandial hypotension, blood pressure, central nervous system stimulants, female, humans, postprandial period, treatment outcome",
author = "Ong, {Alice C. L.} and Myint, {Phyo K.} and Potter, {John F.}",
note = "Funded by The Dunhill Medical Trust. Grant Number: RTF14/0110",
year = "2014",
month = "4",
doi = "10.1111/jgs.12728",
language = "English",
volume = "62",
pages = "649--661",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Pharmacological Treatment of Postprandial Reductions in Blood Pressure

T2 - A Systematic Review

AU - Ong, Alice C. L.

AU - Myint, Phyo K.

AU - Potter, John F.

N1 - Funded by The Dunhill Medical Trust. Grant Number: RTF14/0110

PY - 2014/4

Y1 - 2014/4

N2 - OBJECTIVES: To systematically review the current literature on the pharmacological treatment of postmeal reductions in blood pressure (BP). DESIGN: A systematic literature search and standardized data collection of randomized controlled trials on the pharmacological prevention of postprandial reductions in BP in adults using MEDLINE (1950-), EMBASE (1980-), and CINAHL databases was conducted up to July 2013. Bibliographies of relevant reports were also hand-searched to identify all potentially eligible studies. SETTING: Systematic review of randomized controlled trials using PRISMA guidelines. MEASUREMENTS: Articles were assessed using the Critical Appraisal Skills Programme for randomized controlled trials. RESULTS: Thirteen articles reporting 12 studies (1 study was reported in 2 articles) demonstrated that caffeine (5 studies); acarbose; 3,4-DL-threo-dihydroxyphenylserine; guar gum (3 studies); and octreotide (2 studies) statistically attenuated the postprandial reduction in BP. One caffeine study did not show this. Most studies did not include individuals with symptomatic postprandial hypotension (PPH), so interpretation and application of these findings to this patient group should be made with caution. For symptomatic participants, there was improvement with acarbose but none with caffeine. Differences in the way the data were presented in the studies did not allow for quantification of treatment effects using meta-analysis. CONCLUSION: Drug interventions can attenuate postprandial reductions in BP, but they may not necessarily be effective in people with symptomatic PPH.

AB - OBJECTIVES: To systematically review the current literature on the pharmacological treatment of postmeal reductions in blood pressure (BP). DESIGN: A systematic literature search and standardized data collection of randomized controlled trials on the pharmacological prevention of postprandial reductions in BP in adults using MEDLINE (1950-), EMBASE (1980-), and CINAHL databases was conducted up to July 2013. Bibliographies of relevant reports were also hand-searched to identify all potentially eligible studies. SETTING: Systematic review of randomized controlled trials using PRISMA guidelines. MEASUREMENTS: Articles were assessed using the Critical Appraisal Skills Programme for randomized controlled trials. RESULTS: Thirteen articles reporting 12 studies (1 study was reported in 2 articles) demonstrated that caffeine (5 studies); acarbose; 3,4-DL-threo-dihydroxyphenylserine; guar gum (3 studies); and octreotide (2 studies) statistically attenuated the postprandial reduction in BP. One caffeine study did not show this. Most studies did not include individuals with symptomatic postprandial hypotension (PPH), so interpretation and application of these findings to this patient group should be made with caution. For symptomatic participants, there was improvement with acarbose but none with caffeine. Differences in the way the data were presented in the studies did not allow for quantification of treatment effects using meta-analysis. CONCLUSION: Drug interventions can attenuate postprandial reductions in BP, but they may not necessarily be effective in people with symptomatic PPH.

KW - drug treatment

KW - pharmacological treatment

KW - postprandial hypotension

KW - blood pressure

KW - central nervous system stimulants

KW - female

KW - humans

KW - postprandial period

KW - treatment outcome

U2 - 10.1111/jgs.12728

DO - 10.1111/jgs.12728

M3 - Article

VL - 62

SP - 649

EP - 661

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

IS - 4

ER -